MedPath

Antibiotics for multidrug-resistant tuberculosis: network meta-analysis.

Not Applicable
Conditions
MDR-TB
Registration Number
JPRN-UMIN000039703
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
WHO 2008 defined outcomes. World Health Organization.Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. 2008. Available at: Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Accessed on Mar 1st, 2020.
Secondary Outcome Measures
NameTimeMethod
Adverse effect. Time to culture conversion.
© Copyright 2025. All Rights Reserved by MedPath